Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Scott L. Pomeroy, Marc Remke et al.|Acta Neuropathologica|2016Cited by 650
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Elke Pfaff et al.|Journal of Clinical Oncology|2013Cited by 488
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Ralph P. Ermoian, Thomas Hielscher et al.|Journal of Clinical Oncology|2016Cited by 206
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursAndré O. von Bueren, Stefan Rutkowski|British Journal of Cancer|2012Cited by 46
Addressing gaps and enhancing experiences in support services for families of pediatric cancer survivorsVerena Paul, Corinna Bergelt, Laura Inhestern et al.|Pediatric Research|2024Cited by 18